Accueil > Actualité
Actualite financiere : Actualite bourse

Moderna: 2022 EPS down 29%

( - Moderna has reported FY 2022 sales of $19.
3bn, up from $18.5bn in 2021, with business still driven by increased sales of the company's COVID-19 vaccines.

The company also says that it increased its R&D spending by 65% to $3.3bn.

As a result, net profit fell 31% to $8.4bn, while EPS was down preety much the same (-29%) at $20.12.

Copyright (c) 2023 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.